Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign,...
First patient dosed in Gesynta Pharma’s endometriosis trial of vipoglanstat
STOCKHOLM, March 11, 2026 /PRNewswire/ -- Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal, non-opioid drug candidate for endometriosis. This milestone marks an important step toward a new treatment for the approximately 190 million women worldwide living with this painful, often debilitating,...
IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent
ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced the issuance of U.S. Patent No. 12,558,123, further strengthening its intellectual property portfolio in robotic-assisted cochlear implantation. The iotaSOFT® Robotic-Assisted...
Ulike Announces Official Partnership with the PCOS Awareness Association (PCOSAA)
NEW YORK, March 11, 2026 /PRNewswire/ -- Millions of women worldwide live with Polycystic Ovary Syndrome (PCOS), a complex hormonal condition that remains widely underdiagnosed, stigmatized, and misunderstood. Beyond its medical implications, PCOS often affects mental health, self-esteem, and daily quality of life, particularly through visible symptoms such as excess hair growth. To help address these challenges through education, advocacy,...
DermRays Launches Lumenic™ Dual-Light & 3D-Oscillo™ System for At-Home Professional Teeth Whitening
NEW YORK, March 11, 2026 /PRNewswire/ -- DermRays, a pioneer in medical-grade consumer beauty technology, recently announced the global launch of the Lumenic™ Dual-Light & 3D-Oscillo™ System. This FDA-registered innovation is designed to disrupt the oral care market by offering a painless, professional-grade whitening and repair solution that fits into a daily brushing routine. Dual-Light...
HelpMeSee Featured in “Healthier Together,” Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training
NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together, a branded content series presented by the WHO Foundation. A cataract patient in Mumbai featured in the Healthier Together series undergoes sight-restoring surgery performed by a surgeon trained...
Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 25, 2026
BEIJING, March 11, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. markets open on Wednesday, March 25, 2026....
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, ‘MAV/06’
Demonstrates effectiveness comparable to the global standard Oka strain vaccine YONGIN, South Korea, March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that a review paper comprehensively analyzing the safety and immunogenicity of its independently developed varicella vaccine strain, 'MAV/06', has...
Haier Biomedical Hosts European Partner Summit in Rome and Advances “In Europe, for Europe” Strategy
ROME, March 11, 2026 /PRNewswire/ -- Haier Biomedical recently convened its European Partner Summit in Rome under the theme "Advancing Together - Sharing the Future of Biomedical Innovation," which brought together 37 regional partners and industry leaders from 23 European countries to outline its long-term commitment to Europe and unveil a broadened laboratory solutions portfolio, marking a strategic upgrade...
Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer
SUZHOU, China, March 11, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for the company's Process Development and Analytical Development Department, Production Department and Quality Department, and report to Dr. Ting Xu, Chairman and CEO of Alphamab Oncology. Dr. Hongwei Wang is...
